Evgo Inc. Form 8-K Summary
Business Context and Reporting Period
Evgo Inc. filed this Current Report on Form 8-K under Item 5.02 regarding the appointment and compensation arrangements of its incoming Chief Executive Officer. The report identifies October 31, 2023 as the date of the earliest event reported, was signed November 6, 2023, and describes events scheduled for November 9 and November 13, 2023.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or other financial results.
Material Changes Versus the Prior Comparable Period
No period-over-period financial comparison is provided. The material change disclosed is the planned commencement of Badar Khan’s employment as CEO on November 9, 2023, as previously announced in an August 2, 2023 Form 8-K.
Executive Compensation and Other Key Items
- On November 13, 2023, Mr. Khan is scheduled to receive equity awards under Evgo’s 2021 Long Term Incentive Plan.
- The awards include a one-time time-based restricted stock unit grant valued at $3.0 million.
- The awards include a one-time performance-based restricted stock unit grant valued at $3.0 million.
- Mr. Khan will also receive a prorated 2023 annual award valued at $580,822, consisting of restricted stock units and an option to purchase Class A common stock.
- The number of shares underlying the awards and the option exercise price will be determined under the employment agreement.
- The awards are subject to applicable vesting terms, the incentive plan, and individual award agreements.
- If Mr. Khan is terminated without cause or resigns for good reason, specified unvested portions of the awards will receive accelerated, prorated vesting based on completed months of service since the applicable vesting or grant date.
Guidance, Outlook, Risks, and Contingencies
The filing provides no financial guidance or business outlook. The principal disclosed contingency is the potential accelerated vesting of equity awards upon qualifying termination. The filing text does not provide the specific share counts, vesting schedules, or option exercise price.
Important Facts for Investors to Verify
- Confirm the effective dates of Mr. Khan’s CEO appointment and the equity award grants.
- Review the August 2, 2023 Form 8-K and the employment agreement for complete vesting terms, performance conditions, and termination provisions.
- Verify the final share counts, option exercise price, and accounting impact of the awards when disclosed.
- Assess any subsequent changes to the CEO’s employment, compensation, or equity awards in later SEC filings.